IA
PACB icon

IndexIQ Advisors’s Pacific Biosciences PACB Stock Holding History

IndexIQ Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,532,874
Closed -$7.91M – 817
2019
Q3 		$7.91M Sell
1,532,874
-103,639
-6% -$580K 0.28% 64
2019
Q2 		$9.9M Buy
1,636,513
+624,723
+62% +$4.38M 0.3% 59
2019
Q1 		$7.32M Buy
1,011,790
+224,321
+28% +$1.62M 0.21% 65
2018
Q4 		$5.83M Buy
+787,469
New +$4.99M 0.16% 106

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

IndexIQ Advisors's PACB Position: Q4 2019 in Review

IndexIQ Advisors sold out of Pacific Biosciences (PACB) in Q4 2019, closing a stake of 1,532,874 shares — an estimated $7.91M sold.

IndexIQ Advisors first reported a position in PACB in Q4 2018 and held it in 4 quarters. The position peaked at $9.9M in Q2 2019. 143 funds tracked by Wall St. Rank hold PACB as of Q4 2019.

  • IndexIQ Advisors reported no remaining Pacific Biosciences position as of Q4 2019 after selling out during the quarter.
  • IndexIQ Advisors sold 1,532,874 Pacific Biosciences shares in Q4 2019, an estimated $7.91M.
  • IndexIQ Advisors first reported a position in Pacific Biosciences in Q4 2018 and held it in 4 quarters.
  • IndexIQ Advisors's Pacific Biosciences position peaked at $9.9M in Q2 2019.
  • 143 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2019.

Based on IndexIQ Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.